RYOIX Mutual Fund (Rydex Biotechnology Fund Investor Class) is managed by Rydex Funds with $114.3M in net assets. RYOIX expense ratio is 1.39%, holding 76 positions across sectors including Health Care, Unknown, Materials. Inception date: 1998-04-01.

RYOIX performance shows a YTD return of 3.98%. The 1-year return is 44.37% and the 5-year return is 9.04%. RYOIX dividend yield stands at 12.04%, paid annually.

RYOIX top holdings include Abbvie Inc (8.8%), Amgen Inc. (5.3%), Gilead Sciences Inc (4.9%), Nvaesrtex Pharmaceuticals Inc (4.3%), Alnylam Pharmace (3.3%). View all RYOIX holdings, sector breakdown, or dividend history.

RYOIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RYOIX alternatives are available via the screener, along with tax-loss harvesting opportunities.